Skip to main content

Rossi Dino A's Form 4 filing

Krystal Biotech, Inc. (KRYS) · filed Feb 23, 2026

Accession no.
0001209059-26-000003
Filed
Feb 23, 2026
Trade date
Feb 19, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.95M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rossi Dino ACIK 0001209059Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 19, 2026Common StockMOption exerciseAcquired+18,950$8.79+$166,570.597,641Direct
Feb 19, 2026Common StockSSaleDisposed−8,116$260.49−$2,114,136.8489,525Direct
Feb 19, 2026Common StockSSaleDisposed−10,834$262.10F1−$2,839,591.478,691Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 19, 2026Common StockMOption exerciseDisposed−18,950$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Multiple lots for the same price for this transaction have been combined.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)